Challenge virus | Challenge time pv | Vaccine | Virus isolation from the swabs (shedding/total log 10 EID 50 /mL) | No. surviving/total | |||||
---|---|---|---|---|---|---|---|---|---|
Day 3 pc | Day 5 pc | Day 7 pc | |||||||
Oropharyngeal | Cloacal | Oropharyngeal | Cloacal | Oropharyngeal | Cloacal | ||||
XN/07 | 1Â week | C-KCE-HA | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 7/7 |
C-KCE | 7/7(3.1 ± 0.6) | 5/7(2.4 ± 0.5) | — | — | — | — | 0/7 | ||
PBS | 7/7(4.2 ± 0.5) | 6/7(3.8 ± 0.4) | — | — | — | — | 0/7 | ||
3Â weeks | C-KCE-HA | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 7/7 | |
C-KCE | 7/7(2.7 ± 0.6) | 6/7(2.4 ± 0.6) | — | — | — | — | 0/7 | ||
PBS | 7/7(4.3 ± 0.7) | 7/7(4.3 ± 0.7) | — | — | — | — | 0/7 | ||
12Â weeks | C-KCE-HA | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 7/7 | |
C-KCE | 7/7(2.7 ± 0.7) | 7/7(2.6 ± 1.1) | — | — | — | — | 0/7 | ||
PBS | 7/7(2.1 ± 0.9) | 4/7(1.8 ± 1.2) | — | — | — | — | 0/7 | ||
36Â weeks | C-KCE-HA | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 0/7 | 7/7 | |
C-KCE | 7/7(3.1 ± 0.3) | 6/7(2.1 ± 0.5) | — | — | — | — | 0/7 | ||
PBS | 7/7(2.7 ± 0.7) | 7/7(1.8 ± 0.6) | — | — | — | — | 0/7 |